Common Contracts
2 similar Fourth Supplemental Indenture contracts by Valeant Pharmaceuticals International, Inc.
FOURTH SUPPLEMENTAL INDENTUREFourth Supplemental Indenture • August 3rd, 2012 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • New York
FOURTH SUPPLEMENTAL INDENTURE, dated as of August 2, 2012 (the “Fourth Supplemental Indenture”), by and among Orapharma, Inc., Orapharma Topco Holdings, Inc. (collectively, the “New Guarantors”), Valeant Pharmaceuticals International, a Delaware corporation (the “Company”), and The Bank of New York Mellon Trust Company, N.A., a national banking association, as trustee (the “Trustee”).
FOURTH SUPPLEMENTAL INDENTUREFourth Supplemental Indenture • August 3rd, 2012 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • New York
FOURTH SUPPLEMENTAL INDENTURE, dated as of August 2, 2012 (the “Fourth Supplemental Indenture”), by and among Orapharma, Inc., Orapharma Topco Holdings, Inc. (collectively, the “New Guarantors”), Valeant Pharmaceuticals International, a Delaware corporation (the “Company”), and The Bank of New York Mellon Trust Company, N.A., a national banking association, as trustee (the “Trustee”).
